Skip to main content
. 2026 Feb 9;17:1748950. doi: 10.3389/fphar.2026.1748950

FIGURE 2.

Bar charts showing cellular viability percentages at various concentrations for three drugs: Paclitaxel, Capecitabine, and Doxorubicin. Paclitaxel shows slight viability reduction, Capecitabine a moderate reduction, and Doxorubicin a significant reduction. Concentrations and effects are labeled per chart. Statistical significance indicated by asterisks.

Effects of various concentrations of (A) paclitaxel, (B) capecitabine and (C) doxorubicin on the viability of MDA-MB-231 cells 48 h post-treatment. Cell viability was evaluated via the MTT assay. The data are presented as the means ± SEMs of six independent experiments; * = P < 0.05 and ** = P < 0.01 indicate significant cytotoxic effects.